Spinowitz, Bruce S.

Publications

Sort by

Co-Author Network

selected publications

Course of Hyperkalemia in Patients on Hemodialysis. International journal of nephrology. 2022 Academic Article GET IT
Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE. BMC nephrology. 2022 Academic Article GET IT
Hypokalemia Events With Sodium Zirconium Cyclosilicate and Placebo in Hemodialysis Patients. Kidney international reports. 2022 Academic Article GET IT
Dose effect analysis of sodium zirconium cyclosilicate in hemodialysis patients. Hemodialysis international. International Symposium on Home Hemodialysis. 2021 Letter GET IT
Effectiveness of Sodium Zirconium Cyclosilicate in Hemodialysis Patients With Severe Hyperkalemia. Kidney international reports. 2021 Academic Article GET IT
Consensus-Based Recommendations for the Management of Hyperkalemia in the Hemodialysis Setting. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 2021 Academic Article GET IT
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis. The New England journal of medicine. 2021 Academic Article GET IT
Times cited: 21
Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD. The New England journal of medicine. 2021 Academic Article GET IT
Times cited: 24
Sodium zirconium cyclosilicate increases serum bicarbonate concentrations among patients with hyperkalaemia: exploratory analyses from three randomized, multi-dose, placebo-controlled trials. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2021 Academic Article GET IT
Times cited: 19
Treatment of anemia in difficult-to-manage patients with chronic kidney disease. Kidney international supplements. 2021 Academic Article GET IT
Times cited: 20
Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2021 Academic Article GET IT
Times cited: 52
Clinical Management of Hyperkalemia. Mayo Clinic proceedings. 2020 Review GET IT
Times cited: 14
Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: analysis of multinational real-world data. BMC nephrology. 2020 Academic Article GET IT
Times cited: 56
Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review. PharmacoEconomics - open. 2019 Review GET IT
Times cited: 20
Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE. American journal of nephrology. 2019 Academic Article GET IT
Times cited: 70
Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2019 Academic Article GET IT
Times cited: 30
A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia. Journal of the American Society of Nephrology : JASN. 2019 Academic Article GET IT
Times cited: 121
Randomized Controlled Trial of Subcutaneous Epoetin Alfa-epbx Versus Epoetin Alfa in End-Stage Kidney Disease. Kidney international reports. 2019 Academic Article GET IT
Times cited: 8
Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study. Clinical journal of the American Society of Nephrology : CJASN. 2019 Academic Article GET IT
Times cited: 162
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease. Kidney international. 2019 Academic Article GET IT
Times cited: 13
Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review. Journal of medical economics. 2019 Academic Article GET IT
Times cited: 37
Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease. Journal of diabetes and its complications. 2018 Academic Article GET IT
Times cited: 8
One-year efficacy and safety of the iron-based phosphate binder sucroferric oxyhydroxide in patients on peritoneal dialysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2017 Academic Article GET IT
Times cited: 12
Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease. Kidney international. 2016 Academic Article GET IT
Times cited: 141
Systematic review of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage renal disease population unresponsive to primary vaccination series. Renal failure. 2015 Review GET IT
Times cited: 14
Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2015 Academic Article GET IT
Times cited: 111
Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial. JAMA. 2014 Academic Article GET IT
Times cited: 210
Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis. The New England journal of medicine. 2013 Academic Article GET IT
Times cited: 77
Early initiation of dialysis in patients with chronic progressive kidney failure does not confer a mortality advantage when compared with an approach of late initiation combined with appearance of symptoms or signs of uraemia. Evidence-based medicine. 2010 Comment GET IT
C.E.R.A. once every 4 weeks in patients with chronic kidney disease not on dialysis: The ARCTOS extension study. Hemodialysis international. International Symposium on Home Hemodialysis. 2009 Academic Article GET IT
Times cited: 31
Anaemia management with subcutaneous epoetin delta in patients with chronic kidney disease (predialysis, haemodialysis, peritoneal dialysis): results of an open-label, 1-year study. BMC nephrology. 2009 Academic Article GET IT
Times cited: 7
Ferumoxytol for treating iron deficiency anemia in CKD. Journal of the American Society of Nephrology : JASN. 2008 Academic Article GET IT
Times cited: 242
A randomized study of extended dosing regimens for initiation of epoetin alfa treatment for anemia of chronic kidney disease. Clinical journal of the American Society of Nephrology : CJASN. 2008 Academic Article GET IT
Times cited: 35
Anemia management in patients on peritoneal dialysis: efficacy and safety of epoetin delta. Haematologica. 2008 Academic Article GET IT
Times cited: 4
C.E.R.A. maintains stable control of hemoglobin in patients with chronic kidney disease on dialysis when administered once every two weeks. American journal of nephrology. 2007 Academic Article GET IT
Times cited: 44
The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patients. Kidney international. 2005 Academic Article GET IT
Times cited: 64
Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron products. Nephron. Clinical practice. 2004 Academic Article GET IT
Times cited: 36
Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. American journal of nephrology. 2003 Academic Article GET IT
Times cited: 345
Prediction of single-pool Kt/v based on clinical and hemodialysis variables using multilinear regression, tree-based modeling, and artificial neural networks. Artificial organs. 2003 Academic Article GET IT
Times cited: 4
Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2000 Academic Article GET IT
Times cited: 116
Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II). Controlled clinical trials. 1999 Academic Article GET IT
Times cited: 187
Potential angiotensin-converting enzyme inhibitor-epoetin alfa interaction in patients receiving chronic hemodialysis. Pharmacotherapy. 1998 Academic Article GET IT
Times cited: 13
Effect of angiotensin-converting enzyme inhibitors on response to erythropoietin therapy in chronic dialysis patients. American journal of nephrology. 1998 Academic Article GET IT
Times cited: 25
Fluoxetine in depressed patients on dialysis. International journal of psychiatry in medicine. 1997 Academic Article GET IT
Times cited: 102
Fractional direct dialysis quantification: a new approach for prescription and monitoring hemodialysis therapy. Kidney international. 1996 Academic Article GET IT
Times cited: 19
Dialysis adequacy versus metabolic factors in the clinical assessment of CAPD. Advances in peritoneal dialysis. Conference on Peritoneal Dialysis. 1993 Academic Article GET IT
Times cited: 3
Impact of epoetin beta on dialyzer clearance and heparin requirements. American journal of kidney diseases : the official journal of the National Kidney Foundation. 1991 Academic Article GET IT
Times cited: 20
Transfusion therapy: associated risks and alternative approaches. ANNA journal. 1990 Academic Article GET IT
Times cited: 1
Effect of long-term epoetin beta therapy on the quality of life of hemodialysis patients. ASAIO transactions. 1990 Academic Article GET IT
Times cited: 20
EPO--one year later: a look at rehabilitation. The impact of long-term epoetin beta therapy on ESRD patient quality of life. Nephrology news & issues. 1990 Academic Article GET IT
Times cited: 4
The existence of a protracted course in crescentic glomerulonephritis. Kidney international. 1987 Academic Article GET IT
Subclavian vein stenosis as a complication of subclavian catheterization for hemodialysis. Archives of internal medicine. 1987 Academic Article GET IT
Times cited: 75
Comparison of eosinophilia in patients undergoing peritoneal dialysis and hemodialysis. American journal of kidney diseases : the official journal of the National Kidney Foundation. 1986 Academic Article GET IT
A comparative study of continuous ambulatory peritoneal dialysis and center hemodialysis. Efficacy, complications, and outcome in the treatment of end-stage renal disease. Archives of internal medicine. 1986 Academic Article GET IT
Times cited: 34
Percutaneous transluminal dilatation for vascular access. Nephron. 1983 Academic Article GET IT
Times cited: 9
CAPD peritonitis in perspective. Clinical and experimental dialysis and apheresis. 1982 Academic Article GET IT
Times cited: 1
Continuous ambulatory peritoneal dialysis: establishment and growth of a program in a large metropolitan area. Clinical and experimental dialysis and apheresis. 1982 Academic Article GET IT
Eosinophilic peritonitis. Clinical and experimental dialysis and apheresis. 1982 Academic Article GET IT
Times cited: 15
Technique for implantation of the Toronto-Western catheter at the Booth Memorial Medical Center. Clinical and experimental dialysis and apheresis. 1982 Academic Article GET IT
Times cited: 1
Dialysis eosinophilia. Transactions - American Society for Artificial Internal Organs. 1981 Academic Article GET IT
Times cited: 9
Action of adenosine on chloride active transport of isolated frog cornea. The American journal of physiology. 1979 Academic Article GET IT
Times cited: 17
Dialysance of iodide. The New England journal of medicine. 1978 Letter GET IT
Times cited: 1
Increased production of fructose by the brain in dogs made diabetic by alloxan and by growth hormone. Diabetes. 1973 Academic Article GET IT
Times cited: 3

more ...

less ...

Background

education and training

M.D., New York University School of Medicine 73
B.A., Yeshiva University 1969

Contact

full name

Bruce S. Spinowitz

VIVO Weill Cornell Medical College

Bruce S. Spinowitz Professor of Clinical Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email